Fiasp 100IU/ml Solution for Injection

Fiasp 100 IU/ml Solution for Injection – Fast-Acting Insulin Aspart for Diabetes Management

Fiasp 100 IU/ml Solution for Injection contains Insulin Aspart 100 units/ml, a fast-acting prescription insulin used to improve blood glucose control in adults and children with diabetes mellitus. Fiasp is a mealtime insulin designed to begin working rapidly after administration. It helps control the rise in blood glucose that occurs during and after meals by supporting glucose uptake into body tissues and reducing excess glucose production by the liver. Fiasp may be used in people with type 1 or type 2 diabetes as part of an individualized diabetes-management plan. It is generally used with an intermediate-acting or long-acting basal insulin unless the healthcare provider recommends another treatment regimen.

Key Features

• Contains Insulin Aspart 100 Units/ml: A fast-acting insulin analogue for mealtime glucose control.
• Rapid Mealtime Action: Administered at the beginning of a meal or shortly after the meal starts.
• Supports Blood Glucose Management: Helps control increased blood glucose during and after meals.
• Suitable for Diabetes Treatment: Used in adults and eligible children with diabetes mellitus.
• Multiple Presentations: May be supplied in vials, cartridges, pre-filled pens, or compatible pump cartridges depending on the market.

Active Ingredient

• Insulin Aspart 100 Units/ml: A rapid-acting insulin analogue that helps move glucose from the bloodstream into body cells for energy.

Uses

• Improvement of blood glucose control in adults with diabetes mellitus.
• Management of type 1 diabetes as part of a basal-bolus insulin regimen.
• Management of type 2 diabetes when insulin treatment is required.
• Improvement of mealtime and post-meal blood glucose control.
• Use through a compatible insulin pump when specifically prescribed and supported by the selected presentation.

How to Use

• Use Fiasp exactly as prescribed by your healthcare professional.
• Administer the dose at the start of a meal or within 20 minutes after starting the meal.
• Inject subcutaneously into the abdomen, thigh, or upper arm.
• Rotate injection sites within the same body region to reduce the risk of skin thickening, pits, lumps, or localized deposits.
• Do not inject into skin that is thickened, pitted, lumpy, bruised, damaged, or scarred.
• Do not inject into a muscle unless specifically instructed by a healthcare professional.
• Do not change the dose, insulin type, or treatment schedule without medical supervision.
• Check blood glucose regularly according to the diabetes-management plan provided by your healthcare professional.

Important Administration Instructions

• Check the label before every injection to avoid confusion with another insulin product.
• The solution should appear clear and colourless.
• Do not use the solution if it appears cloudy, coloured, thickened, or contains visible particles.
• Use a new sterile needle for each injection when using a compatible injection pen.
• Remove the needle from the pen immediately after each injection.
• Never share a vial, cartridge, pre-filled pen, injection device, syringe, or needle with another person.
• Do not withdraw insulin from a pre-filled FlexTouch pen using a syringe.
• Do not mix Fiasp with another insulin unless specifically permitted by the official instructions and directed by a healthcare professional.

Precautions

• Do not use Fiasp during an episode of low blood glucose.
• Inform your doctor if you have kidney disease, liver disease, low potassium levels, heart failure, or recurrent hypoglycaemia.
• Tell your healthcare provider about all insulin products, diabetes medicines, prescription medicines, vitamins, and supplements you use.
• Changes in diet, physical activity, body weight, illness, alcohol intake, or other medicines may affect insulin requirements.
• Insulin requirements may change during pregnancy, breastfeeding, illness, surgery, or periods of emotional or physical stress.
• Carry a suitable source of fast-acting glucose as advised by your healthcare professional.
• Do not drive or operate machinery when experiencing symptoms of low blood glucose.

Warning

• Hypoglycaemia: Low blood glucose is the most common adverse effect of insulin and may cause sweating, shaking, hunger, dizziness, confusion, blurred vision, seizures, unconsciousness, or death.
• Hyperglycaemia: Missed doses, insufficient insulin, pump malfunction, infection, or incorrect administration may cause dangerously high blood glucose.
• Severe Allergic Reactions: Seek emergency medical assistance for facial swelling, breathing difficulty, widespread rash, dizziness, or rapid heartbeat.
• Low Potassium: Insulin may reduce potassium levels in the blood, particularly in susceptible patients.
• Medication Errors: Using the wrong insulin or selecting an incorrect dose may cause severe hypoglycaemia or hyperglycaemia.
• Changes to an insulin regimen should be made only under close medical supervision with increased blood glucose monitoring.

Common Side Effects

• Low blood glucose.
• Injection-site redness, swelling, itching, or discomfort.
• Skin thickening, pits, or lumps at frequently used injection sites.
• Weight gain.
• Swelling caused by fluid retention.
• Skin rash or itching.

Storage

• Store unopened Fiasp in a refrigerator between 2°C and 8°C.
• Do not freeze and do not use the medicine if it has been frozen.
• Keep the product in its original carton to protect it from light.
• Protect from excessive heat and direct sunlight.
• Opened vials may generally be stored refrigerated or below 30°C for up to 28 days.
• In-use FlexTouch pens may generally be stored below 30°C or refrigerated for up to 28 days without a needle attached.
• In-use PenFill cartridges should generally be stored below 30°C and should not be refrigerated.
• Storage periods may differ for PumpCart or other presentations; follow the instructions supplied with the exact product.
• Discard the product after the recommended in-use period even if insulin remains.
• Keep out of reach of children.

Legal Disclaimer: Fiasp 100 IU/ml Solution for Injection is a prescription insulin medicine that must be used under the supervision of a qualified healthcare professional. Incorrect dosing may cause severe or life-threatening hypoglycaemia or hyperglycaemia. This information is provided for educational purposes only and should not replace professional medical advice, diabetes training, blood glucose monitoring, or the official instructions supplied with the medicine.